Nicotine

Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update

Retrieved on: 
Thursday, November 9, 2023
NDA, Small business, Webcast, Smoker, Annual general meeting, Herbal cigarette, U.S.–Canada Team Tournament (Go), International, Headache, ASP, FDA, Nicotine, Smoke, Pharmacokinetics, New Drug Application, Data analysis, American Society of Pharmacognosy, Cytisine, Nausea, Kidney, Insomnia, Society, JAMA, Smoking, Pharmaceutical industry, Cryptocurrency

“This has been a pivotal year for Achieve and we made significant strides to continue our progress on advancing cytisinicline throughout the third quarter,” said John Bencich, CEO of Achieve.

Key Points: 
  • “This has been a pivotal year for Achieve and we made significant strides to continue our progress on advancing cytisinicline throughout the third quarter,” said John Bencich, CEO of Achieve.
  • This trial, conducted in the United States, showcased the effectiveness and excellent tolerability of cytisinicline in adult smokers.
  • The panel highlighted the importance of industry and public partnerships in advancing new treatments, with Achieve representing an exemplary example.
  • Data analysis and final study reports for all 3 studies are expected to be completed in early 2024.

Nicole Avena, PhD, Announces Latest Book Sugarless: A 7-Step Plan to Uncover Hidden Sugars, Curb Your Cravings, and Conquer Your Addiction

Retrieved on: 
Monday, December 4, 2023
Entertainment, Health, Neurology, Fitness & Nutrition, Books, General Health, Pulitzer Prize, Diet, Cocaine, Brain, Research, Amazon, MSL, Psychology, Food, Book, Sugar, Nicotine, Science, Princeton University, Neuroscience, MD, Doctor of Philosophy, Rockefeller University, Sugarless, Medicine, Nucleotide sugars metabolism

Today, she's the world's leading expert on sugar addiction, and her findings have informed our overall understanding of nutrition and health.

Key Points: 
  • Today, she's the world's leading expert on sugar addiction, and her findings have informed our overall understanding of nutrition and health.
  • However, her goal goes beyond raising the alarm; she offers a practical plan that doesn't require going cold turkey.
  • Nicole Avena, PhD, is a pioneering research neuroscientist and expert in the fields of nutrition, diet, and addiction.
  • Sugarless is published by Union Square & Co. and available for pre-order on Amazon and is available in stores December 19.

Qnovia, Inc. announces positive results from first-in-human pharmacokinetic and safety study of lead asset QN-01, a prescription inhaled smoking cessation therapy

Retrieved on: 
Wednesday, November 29, 2023
Science, Other Science, Pharmaceutical, Health, Tobacco, Health Technology, Clinical Trials, Retail, Smoker, IND, Plasma, MHRA, Patient, Multimedia, Smoke, Nicotine, Tmax, Initial, Pharmacokinetics, CDER, Medication, Therapy, NRT, Cmax, CTA, Smoking cessation, Smoking, Pharmaceutical industry, Research

Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRxTM, today announced positive results from its first in-human study of QN-01, the company’s lead asset.

Key Points: 
  • Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRxTM, today announced positive results from its first in-human study of QN-01, the company’s lead asset.
  • QN-01 is an inhaled smoking cessation therapy that is currently being evaluated in the U.S. under FDA’s Center for Drug Evaluation and Research (CDER) and in the U.K. by the Medicines and Healthcare Products Regulatory Agency (MHRA).
  • “We are delighted to share that QN-01 demonstrated a superior pharmacokinetic profile compared to an existing inhaled NRT and was well tolerated.
  • The drug-device combination was well tolerated with no severe adverse events and few minor adverse events typical of inhaled nicotine.

Travis Parman Joins Philip Morris International as Vice President, Chief Communications Officer, U.S.

Retrieved on: 
Monday, November 27, 2023
Tobacco, Retail, Smoke, Sale, ZYN, Spokesperson, IQOS, Research, NYSE, PMI, Food, Toxicology, Ally Financial, General Motors, Nicotine, Appharvest, PulteGroup, Philip Morris International, University, Syracuse University, Life

Philip Morris International Inc. (PMI) (NYSE: PM) announced today that it has appointed Travis Parman Vice President, Chief Communications Officer, U.S. Parman will lead communications for PMI’s U.S. business as the company progresses toward its goal of delivering a smoke-free future for adults who currently smoke and would otherwise not quit.

Key Points: 
  • Philip Morris International Inc. (PMI) (NYSE: PM) announced today that it has appointed Travis Parman Vice President, Chief Communications Officer, U.S. Parman will lead communications for PMI’s U.S. business as the company progresses toward its goal of delivering a smoke-free future for adults who currently smoke and would otherwise not quit.
  • “We are thrilled that Travis is joining us in our bold ambition to deliver a smoke-free future in the United States.
  • He previously held multiple roles with the Renault-Nissan-Mitsubishi Alliance in Paris, Nashville, and Yokohama, Japan—most recently as VP, International Communications and Global Engagement.
  • Parman holds a master’s degree in communications management from the Newhouse School of Public Communications at Syracuse University and a bachelor’s degree in communications from the University of Tennessee.

US Nicotine Market Insights and Forecasts to 2027: Growing Popularity of Tobacco Free Oral Nicotine - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 22, 2023
Tobacco, Retail, Pomegranate, Carbon, Tablet, Lip, Chewing gum, Altria, Fruit, Work, Nicotine

Thus, an upsurge in working population indicates increase in demand for nicotine products, which in turn, provided a boost to the overall market growth.

Key Points: 
  • Thus, an upsurge in working population indicates increase in demand for nicotine products, which in turn, provided a boost to the overall market growth.
  • The popularity of oral tobacco free nicotine gummies and lozenges is expected to sustain during projected years thus, maintaining a stable demand in the coming years.
  • The US nicotine market is concentrated due to the presence of a relatively small number of market participants.
  • Altria is the market leader in Tobacco products and held a dominant share of the total nicotine industry.

Star 12000: A Visual Masterpiece Redefining Vaping in the Middle East

Retrieved on: 
Friday, December 15, 2023
Eye, Sensation, GCC, Nicotine, MENA

SHENZHEN, China, Dec. 15, 2023 /PRNewswire/ -- VOZOL's latest breakthrough, the Star 12000, has officially hit the Middle East market in October 2023.

Key Points: 
  • SHENZHEN, China, Dec. 15, 2023 /PRNewswire/ -- VOZOL's latest breakthrough, the Star 12000, has officially hit the Middle East market in October 2023.
  • This compact disposable vape device packs a punch with 12,000 puffs, offering a tailored vaping experience for the region.
  • VOZOL's new Star 12000 maintains the proven S.I.L.C technology from Gear 10000, which previously earned immense success in the Middle East.
  • Building on the success of previous products like Gear10000 and Neon10000, VOZOL consistently delivers innovative vaping experiences for Middle Eastern consumers.

Spliffy: Revolutionizing Last-Mile Delivery in Knoxville and Beyond

Retrieved on: 
Tuesday, December 5, 2023
City, Heart, THCA, Multimedia, Life, Gopuff, Smoke, Nicotine, Retail, Online shopping, Cannabis

KNOXVILLE, Tenn., Dec. 5, 2023 /PRNewswire/ -- In the heart of Knoxville, TN, a groundbreaking delivery service is making waves—meet Spliffy, the city's first true cannabis delivery service.

Key Points: 
  • KNOXVILLE, Tenn., Dec. 5, 2023 /PRNewswire/ -- In the heart of Knoxville, TN, a groundbreaking delivery service is making waves—meet Spliffy, the city's first true cannabis delivery service.
  • Operating in Knoxville as a test-run city, Spliffy plans to expand its platform to cities nationwide, aiming to revolutionize the Last-Mile Delivery industry.
  • In summary, Spliffy.com is not just a delivery service; it's a game-changer in many industries, such as the Cannabis, Alcohol, Technology, and Last-Mile Delivery industries.
  • With its pioneering approach to product diversity, fast and free delivery options, and a visionary rewards program, Spliffy is setting the stage for a delivery revolution in Knoxville and beyond.

It's Time to End the Menthol Poisoning of Communities

Retrieved on: 
Tuesday, December 5, 2023
Smoker, Brain, Heated tobacco product, OMB, White, FDA, Nicotine, Tobacco industry, National Alliance, Menthol, Management, Death, Nation, Tobacco, Doctor of Philosophy, Life

WASHINGTON, Dec. 5, 2023 /PRNewswire/ -- "For decades, the tobacco industry has used menthol and flavored products to deliberately target and addict Hispanic and other targeted communities in a callous campaign to increase profit. The White House Office of Management and Budget (OMB) can stop it now. Sitting at OMB are proposed rules from the FDA, that have been decades in the making, to ban menthol in cigarettes and flavors in cigars. A ban on menthol this month would save over 15,000 lives next year. Action can simply no longer be delayed," said Jane L. Delgado, PhD, MS, President and CEO of the National Alliance for Hispanic Health, the Nation's leading Hispanic health advocacy group.

Key Points: 
  • WASHINGTON, Dec. 5, 2023 /PRNewswire/ -- "For decades, the tobacco industry has used menthol and flavored products to deliberately target and addict Hispanic and other targeted communities in a callous campaign to increase profit.
  • Sitting at OMB are proposed rules from the FDA, that have been decades in the making, to ban menthol in cigarettes and flavors in cigars.
  • A ban on menthol this month would save over 15,000 lives next year.
  • Ongoing delays in enactment of these rules is literally a matter of life and death," concluded Dr. Delgado.

Angela "Blac Chyna" White Signs "Multi-Million" Dollar Partnership with Passes

Retrieved on: 
Friday, December 1, 2023
Spirituality, OnlyFans, White, Nicotine, Music, Pass

MIAMI, Dec. 1, 2023 /PRNewswire/ -- Passes, a subscription-based, community-driven platform, today announced entertainer and entrepreneur Angela White, also known as "Blac Chyna," has joined the platform where she will share exclusive content with subscribers. Angela has been one of the top creators on OnlyFans since 2020, but is now transitioning to a platform that empowers her to connect with her fans on a deeper, more intimate level while sharing content that focuses on her healthy mind, body and spirit.

Key Points: 
  • MIAMI, Dec. 1, 2023 /PRNewswire/ -- Passes , a subscription-based, community-driven platform, today announced entertainer and entrepreneur Angela White, also known as "Blac Chyna," has joined the platform where she will share exclusive content with subscribers.
  • "I am so grateful to join Passes, a female-owned platform that lets me show my true self to better connect with my growing community," said Angela "Blac Chyna" White.
  • "The last year has been transformative for my mental and physical health, and I look forward to sharing more of that journey on Passes.
  • We are thrilled to welcome Angela and her fans to the platform!"

Accorto Regulatory Solutions and Inter Scientific Enter Strategic Alliance to Deliver an Integrated Single-Point Solution for Clients

Retrieved on: 
Tuesday, November 28, 2023
NDA, Safety, MDR, ISO, Medicine, FDA, Nicotine, US FDA, APPH, Publishing, News, Public, Medical device, Industrial design, Management

RICHMOND, Va. and LIVERPOOL, England, Nov. 28, 2023 /PRNewswire/ -- Accorto Regulatory Solutions, LLC.

Key Points: 
  • RICHMOND, Va. and LIVERPOOL, England, Nov. 28, 2023 /PRNewswire/ -- Accorto Regulatory Solutions, LLC.
  • The two companies aspire to use this alliance to streamline the regulatory application development process on behalf of global clients, providing a market leading turn-key solution for both regulatory support and associated analytical data development.
  • Inter Scientific co-founder David Lawson said, "We are thrilled to unveil our strategic alliance with Accorto.
  • "We are continuously looking for opportunities to add value to the services we provide, and having trusted partners like Inter Scientific allows us to do just that."